Salinomycin sodium veterinary grade is incorporated into broiler medicated feed by stepwise dilution from a concentrated premix. In feed mills equipped with ribbon mixers of 1,000–3,000 kg capacity, the API premix is first combined with ground calcium carbonate or rice hulls at a 1:10 ratio and then diluted 1:100 before addition to the final mixed ration. The approved inclusion rate in complete feed for broiler chickens under FDA 21 CFR 558.550 is 40–60 g/ton, equivalent to 44–66 mg/kg, and the label indication covers coccidiosis caused by Eimeria acervulina, E. maxima, E. tenella, E. necatrix, E. brunetti, and E. mivati. A coefficient of variation for tracer or active substance below 5–10% is required to avoid hot spots that would expose individual birds to ionophore overage. The granulated premix form is generally produced by low-shear pot granulation using a binder solution of hydroxypropyl methylcellulose or starch paste; granulate D50 is maintained between 200–400 µm to limit segregation from ground maize, with sieve analysis performed according to ISO 2591-1:1988. Dust is controlled by adding 0.5–1.0% food-grade vegetable oil to the premix, but this addition is a physical dust-suppression step and does not alter the pharmacologically active dose. After pelleting, retained samples from the beginning, middle, and end of each production run are assayed by reversed-phase HPLC using the general method of Ph. Eur. 2.2.29; recovery outside 90–110% of label claim triggers a batch rejection under most feed-inspection release protocols. The U.S. registration does not assign a withdrawal period for broiler chickens at the approved use rate, but this is not a universal regulatory position and must be verified against the importing jurisdiction. Because salinomycin is lethal to equines and turkeys at low concentrations, the mixer, bucket elevator, drag conveyor, cooler, and pellet die must be flushed with ground corn or rice hulls before any horse or turkey feed is manufactured on the same line.

The dry powder form is more sensitive to humidity than the granulated premix. At relative humidity above 60%, salinomycin sodium powder can form agglomerates that stratify in the mixer and do not pass through a 500 µm safety screen at the feed mill. Pre-drying of the carrier at 60 °C for 2 hours and the addition of 0.2–0.5% fumed silica or precipitated silica as a glidant improve flow, but over-blending beyond 15 minutes can raise the fine-particle fraction and create dust. Dust extraction systems must not recycle collected salinomycin powder as a feed ingredient; the superpotent fines from a cyclone baghouse are not a homogeneous working sample and can create an assay overage if returned to the mixer. On-site top-dressing of salinomycin powder onto finished feed is not uniformly authorised; where it is permitted, the powder must be weighed to the nearest 0.1 g per batch and mixed by hand for no less than 10 minutes using a dedicated non-porous paddle and bucket. The absence of this step is a documented cause of field toxicity reports, particularly where the product is added directly to a suspended feeding line without lateral mixing.

What Limits Drinking-Water Solution Stability When Salinomycin Sodium Is Administered Through Proportioners?

Drinking-water medication with salinomycin sodium is not a universally registered route, and the formulation problem is controlled by the pH-dependent ionisation of the ionophore carboxylate salt. In aqueous vehicles, the sodium salt remains predominantly ionised above pH 5.5; acidification below pH 5.0 shifts the equilibrium toward the free-acid form, which is poorly water-soluble and tends to adhere to proportioner tubing, filter membranes, and drinker line biofilm. Farm water with pH above 9.0 can promote base-catalysed hydrolysis or oxidative degradation; therefore the measurable working window for stock-solution recovery is usually between pH 5.5 and 8.0, confirmed by HPLC assay according to Ph. Eur. 2.2.29. The proportioner must be calibrated against actual water flow, not nominal pressure, and a 50–100 µm in-line filter should be installed upstream of the medicator to retain undissolved free acid that forms if a batch of water is accidentally acidified with organic acids during sanitation. If the farm water carries bicarbonate hardness above 300 mg/L as CaCO₃, calcium and magnesium ions can compete with sodium at the carboxylate site and generate poorly soluble carboxylate complexes; published data for this specific configuration is limited, but visual turbidity and a loss of filterable salinomycin on a 0.45 µm membrane are early indicators. Stock solutions in low-density polyethylene tanks should be protected from light and used within 24 hours because non-preserved water supports microbial growth that can adsorb ionophore molecules onto cell biomass and reduce the recovered concentration in the drinking line. A farm-specific in-use stability study should sample the water after 6, 12, and 24 hours and compare peak areas against a freshly prepared reference solution; no single expiry period applies across all water chemistries. Injectable administration is not a straightforward extension of oral solution because the ionophore is poorly tolerated at parenteral pH and the narrow therapeutic index does not support a commercial injectable label for food-producing animals.

Compressed tablets and hard-shell capsules containing salinomycin sodium are not primary commercial presentations for poultry because the flock-level route is feed or water, but the API is occasionally incorporated into oral solids for individual animal use in ruminant markets where a salinomycin product is registered. Direct compression of the pure API is usually unsuitable because the material has low bulk density and is prone to capping; a dry granulation or slugging step with microcrystalline cellulose, croscarmellose sodium, and magnesium stearate is therefore employed. Tablet hardness is typically set between 5–8 kp to achieve disintegration below 15 minutes in 0.1 N HCl at 37 °C when tested by the USP <701> apparatus, but the pharmacopoeial method is a general quality control tool and does not by itself demonstrate bioequivalence in ruminant gastric fluid. Capsule formulations require the API to be pre-blended with lactose monohydrate and a flow aid; segregation is assessed by sampling the blend from the hopper at 0%, 50%, and 100% discharge and comparing salinomycin content by HPLC. Because published data for this specific configuration is limited, the formulator should not extrapolate dissolution profiles from monensin or lasalocid and must verify a stability-indicating method under ICH Q2(R1) conditions. Cross-contamination control is equally critical for capsule and tablet manufacturing, as trace residues above 1 mg/kg in non-target species feed or dosage units would present a serious toxicity risk to equines and turkeys.

Granule Hardness and Particle-Segregation Control in High-Speed Auger and Pneumatic Transfer Lines

The granulated premix form is subjected to mechanical stress in bucket elevators, drag-chain conveyors, and pneumatic transfer lines; attrition generates fines that segregate from the larger carrier particles and deposit salinomycin in dead zones. A target granule hardness of 2–4 N measured by a radial compression tester and a friability below 2.0% after 100 revolutions in a Roche friabilator are common internal specifications, but published data for this specific configuration is limited. The particle-size distribution of the granulate should be controlled by sieve analysis according to ISO 2591-1:1988 so that the D10 is not below 100 µm and the D90 is not above 800 µm; this range reduces the electrostatic adhesion of fines to mixer walls and the classification that occurs during high-speed auger transfer. Bulk density of the final granulate is typically maintained between 0.60 and 0.85 g/cm³ to match the carrier density of ground corn; if the densities diverge by more than 0.20 g/cm³, vibration during transport will stratify the active granulate to the top of the feed bin. Pneumatic conveying of salinomycin granules at air velocities above 20 m/s can fracture particles and raise the sub-50 µm dust fraction; a cyclone or baghouse return stream should be reintroduced only after assay because the returned fines may be superpotent. In high-humidity transfer rooms, granulate surfaces become tacky and cake on the sides of receiving bins; this increases the risk that later batches of non-medicated feed are contaminated when the bin is emptied through the same discharge gate.

When a Drinking-Water Solution Replaces a Premix During a Broiler House Coccidiosis Outbreak

During an active outbreak, feed intake falls and water consumption may also become erratic; switching to a drinking-water salinomycin solution requires the dose to be tied to measured water intake rather than to an assumed body-weight formula. A stock solution of 1,000 mg/L salinomycin sodium is frequently prepared, and the proportioner is set to deliver 25–50 mL of stock solution per litre of drinking water, but this ratio must be corrected when the birds consume less than 70% of their normal water volume. Hard water with iron above 0.3 mg/L can discolour the solution and accelerate oxidative loss; filtration through a 5 µm cartridge followed by UV irradiation at 254 nm reduces microbial and particulate interference but does not remove dissolved cations. Concurrent use of tiamulin or other pleuromutilins is contraindicated because the interaction delays salinomycin clearance and can produce ionophore toxicity even at approved feed concentrations, a restriction that appears in the prescribing information for most salinomycin and tiamulin products. At flock level, water medication should be supplemented with litter moisture management and coccidial lesion scoring at necropsy; the lesion score and oocyst per gram values are the only direct observations that confirm waterborne salinomycin reached the intestinal site of action. If water intake drops below 60% of baseline for more than 12 hours, the flock should be evaluated for alternative supportive therapy because underdosing in a reduced-water-intake crisis is a known farm-level failure mode. Continuous administration through a proportioner is not the same as a pulse-dose approach; pulse dosing can create transient subtherapeutic concentrations in the caecal lumen and should not be substituted without veterinary authorisation.

Parenteral Salinomycin: pH Limits, Tissue Tolerance, and the Absence of a Validated Injectable Label

Injectable salinomycin sodium is not a registered or recommended veterinary presentation for food-producing animals; an injectable dosage form therefore requires a feasibility review rather than a standard manufacturing procedure. The sodium salt is ionised at neutral to mildly alkaline pH, but parenteral vehicles with pH above 9.0 risk base-catalysed degradation, while acidification below pH 5.0 can cause free-acid precipitation; a physically stable solution may require a co-solvent system of propylene glycol and polyethylene glycol 400 buffered to pH 6.0–8.0. Even with a physically stable vehicle, the ionophore mechanism that disrupts cation gradients across cell membranes also produces injection-site irritation, muscle necrosis, and systemic toxicity if the dose reaches 2–5 mg/kg in sensitive species; published data for this specific configuration is limited, and no injectable salinomycin product has an established MRL under Regulation (EC) No 470/2009. For food-producing animals, a parenteral route would require an additional residue-depletion study in edible tissues and a validated withdrawal period that cannot be inferred from feed premix data. In research or non-food animal use, every injectable preparation should be filtered through a 0.22 µm membrane and tested for bacterial endotoxins according to Ph. Eur. 2.6.14 because salinomycin sodium powder is not a sterile API and carries a bioburden typical of fermentation-derived products. Particulate matter in the final injectable should be evaluated by the light obscuration method of USP <788>; visible precipitates are not acceptable merely because the active substance is poorly water-soluble.

The following table aligns each salinomycin dosage-form route with the primary physical or chemical control variables and the reference method that should be used when a batch is released. The table is not a substitute for registration-specific monographs but provides the minimum analytical anchors for a veterinary-grade API user.